This publication uses cookies

We use functional and analytical cookies to improve our website. In addition, third parties place tracking cookies to display personalised advertisements on social media. By clicking accept you consent to the placement of these cookies.

TB remains the bacterial pathogen responsible for the greatest burden of disease, causing well over a million deaths every year. Control of TB has been set back markedly by the COVID-19 pandemic, and drug resistance is a growing global challenge. Methods of timely diagnosis and shorter treatment regimens remain key goals for clinical TB research, alongside the development of vaccines to prevent TB infection and progression to active disease.


4 grants
€51.19 M

19 grants
€76.88 M

10 grants
€66.76 M

33 grants
€194.83 M

Tuberculosis in numbers 
Featured projects